跳至主要内容
临床试验/NCT02090803
NCT02090803已完成不适用

Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells , Prospective, Open, Multicenter Study

Institut de Cancérologie de la Loire3 个研究点 分布在 1 个国家目标入组 189 人开始时间: 2012年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
189
试验地点
3
主要终点
HHV-6 biological reactivation

研究概览

简要总结

The purpose of this study is to assess the human herpes virus reactivation 6 post autologous stem cells in 196 patients. The aim of our study was to describe the incidence of reactivation of HHV-6 in patients requiring autologous HSCT and determine the pathogenic role in this target population.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • all patients hospitalized in the Hematology Clinic of Saint-Etienne and Clermont-Ferrand and receiving autologous hematopoietic stem cells, according to the decision of the Consultative Meeting Multidisciplinary service;
  • Autologous recipients are included irrespective of causal hemopathy (myeloma, lymphoma, acute leukemia, mainly).

排除标准

  • The non-consenting patients or unable to give consent

结局指标

主要结局

HHV-6 biological reactivation

时间窗: 40 days

HHV-6 biological reactivation (blood viral load) is defined by a detectable viral load HHV-6 and\> 450 copies / mL on two occasions one week apart.

次要结局

  • Reconstitution of hematopoiesis(40 days)
  • Disease HHV-6(40 days)
  • Aplasia output or engraftment(40 days)

研究者

发起方
Institut de Cancérologie de la Loire
申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验